Skip to Content
Uncategorized

Stunted Stem Cell Research

There are two previously unreported problems with the stem cell lines approved by the Bush administration, the Washington Post reports today. One study finds that all approved lines share a previously unrecognized trait that fosters rejection by the immune systems,…
October 29, 2004

There are two previously unreported problems with the stem cell lines approved by the Bush administration, the Washington Post reports today. One study finds that all approved lines share a previously unrecognized trait that fosters rejection by the immune systems, “diminishing their potential as medical treatments.” And another study has concluded that at least one-fourth of the approved lines (there are 22 of them) are so difficult to keep alive that they have little potential, even as research tools.

Such news may be too late to affect the presidential election–and no doubt anyone who’s going to vote on the single issue of stem cells has already made up his or her mind one way or the other–but it might add yet more wood on the fire of California’s Proposition 71. In a recent poll, 53% of respondents favored Prop. 71’s passage and only 34% opposed.

Keep Reading

Most Popular

Geoffrey Hinton tells us why he’s now scared of the tech he helped build

“I have suddenly switched my views on whether these things are going to be more intelligent than us.”

Meet the people who use Notion to plan their whole lives

The workplace tool’s appeal extends far beyond organizing work projects. Many users find it’s just as useful for managing their free time.

Learning to code isn’t enough

Historically, learn-to-code efforts have provided opportunities for the few, but new efforts are aiming to be inclusive.

Deep learning pioneer Geoffrey Hinton has quit Google

Hinton will be speaking at EmTech Digital on Wednesday.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.